Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person UniProt:Q13825 AUH
| Class:Id | ReferenceGeneProduct:85696 |
|---|---|
| _chainChangeLog | transit peptide:1-67 added on Fri February 6 2015;chain:68-339 added on Fri February 6 2015 |
| _displayName | UniProt:Q13825 AUH |
| _timestamp | 2025-05-21 21:04:03 |
| chain | transit peptide:1-67 chain:68-339 |
| checksum | E04FEB95933FB30B |
| comment | FUNCTION Catalyzes the fifth step in the leucine degradation pathway, the reversible hydration of 3-methylglutaconyl-CoA (3-MG-CoA) to 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) (PubMed:11738050, PubMed:12434311, PubMed:12655555, PubMed:16640564). Can catalyze the reverse reaction but at a much lower rate in vitro (PubMed:16640564). HMG-CoA is then quickly degraded by another enzyme (such as HMG-CoA lyase) to give acetyl-CoA and acetoacetate (PubMed:16640564). Uses other substrates such as (2E)-glutaconyl-CoA efficiently in vitro, and to a lesser extent 3-methylcrotonyl-CoA (3-methyl-(2E)-butenoyl-CoA), crotonyl-CoA ((2E)-butenoyl-CoA) and 3-hydroxybutanoyl-CoA (the missing carboxylate reduces affinity to the active site) (PubMed:16640564). Originally it was identified as an RNA-binding protein as it binds to AU-rich elements (AREs) in vitro (PubMed:7892223). AREs direct rapid RNA degradation and mRNA deadenylation (PubMed:7892223). Might have itaconyl-CoA hydratase activity, converting itaconyl-CoA into citramalyl-CoA in the C5-dicarboxylate catabolism pathway (PubMed:29056341). The C5-dicarboxylate catabolism pathway is required to detoxify itaconate, an antimicrobial metabolite and immunomodulator produced by macrophages during certain infections, that can act as a vitamin B12-poisoning metabolite (PubMed:29056341).CATALYTIC ACTIVITY (3S)-3-hydroxy-3-methylglutaryl-CoA = 3-methyl-(2E)-glutaconyl-CoA + H2OCATALYTIC ACTIVITY (3S)-citramalyl-CoA = itaconyl-CoA + H2OCATALYTIC ACTIVITY 3-hydroxyisovaleryl-CoA = 3-methylbut-2-enoyl-CoA + H2OCATALYTIC ACTIVITY (S)-3-hydroxyglutaryl-CoA = (2E)-glutaconyl-CoA + H2OBIOPHYSICOCHEMICAL PROPERTIES Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 3/3.SUBUNIT Homohexamer.SUBCELLULAR LOCATION The disease is caused by variants affecting the gene represented in this entry.SIMILARITY Belongs to the enoyl-CoA hydratase/isomerase family. |
| description | recommendedName: fullName evidence="8"Methylglutaconyl-CoA hydratase, mitochondrial shortName evidence="8"3-MG-CoA hydratase ecNumber evidence="3 5"4.2.1.18 alternativeName: AU-specific RNA-binding enoyl-CoA hydratase shortName: AU-binding protein/enoyl-CoA hydratase alternativeName: fullName evidence="9"Itaconyl-CoA hydratase ecNumber evidence="9"4.2.1.56 |
| geneName | AUH |
| identifier | Q13825 |
| isSequenceChanged | FALSE |
| keyword | 3D-structure Acetylation Alternative splicing Branched-chain amino acid catabolism Direct protein sequencing Disease variant Lyase Mitochondrion Proteomics identification Reference proteome RNA-binding Transit peptide |
| modified | [InstanceEdit:9836292] Weiser, Joel, 2023-05-25 [InstanceEdit:9852000] Weiser, Joel, 2023-11-03 [InstanceEdit:9917590] Weiser, Joel, 2024-08-09 [InstanceEdit:9926675] Weiser, Joel, 2024-11-03 [InstanceEdit:9939033] Weiser, Joel, 2025-02-21 [InstanceEdit:9948485] Weiser, Joel, 2025-05-21 |
| name | AUH |
| referenceDatabase | [ReferenceDatabase:2] UniProt |
| referenceGene | [ReferenceDNASequence:9004553] ENSEMBL:ENSG00000148090 AUH [Homo sapiens] |
| secondaryIdentifier | AUHM_HUMAN B1ALV7 B1ALV8 Q8WUE4 |
| sequenceLength | 339 |
| species | [Species:48887] Homo sapiens |
| (isoformParent) | [ReferenceIsoform:144417] UniProt:Q13825-2 AUH [Homo sapiens] [ReferenceIsoform:405663] UniProt:Q13825-1 AUH [Homo sapiens] |
| (referenceEntity) | [EntityWithAccessionedSequence:70775] AUH [mitochondrial matrix] [Homo sapiens] [EntityWithAccessionedSequence:9914312] G217D AUH [mitochondrial matrix] [Homo sapiens] [EntityWithAccessionedSequence:9914314] R331* AUH [mitochondrial matrix] [Homo sapiens] [EntityWithAccessionedSequence:9914316] A240V AUH [mitochondrial matrix] [Homo sapiens] [EntityWithAccessionedSequence:9914323] R197* AUH [mitochondrial matrix] [Homo sapiens] |
| (referenceSequence) | [NonsenseMutation:9914313] Nonsense mutation at L-lysine 331 [NonsenseMutation:9914317] Nonsense mutation at L-arginine 197 [ReplacedResidue:9914319] glycine 217 replaced with L-aspartic acid [ReplacedResidue:9914322] L-alanine 240 replaced with L-valine |
| [Change default viewing format] | |
No pathways have been reviewed or authored by UniProt:Q13825 AUH (85696)
